|
Vol. 273, Issue 1, 466-474, January 2, 1998
Structural Elucidation and Monokine-inducing Activity of Two
Biologically Active Zwitterionic Glycosphingolipids Derived from
the Porcine Parasitic Nematode Ascaris suum*
Günter
Lochnit,
Roger D.
Dennis,
Artur J.
Ulmer , and
Rudolf
Geyer§
From the Institute of Biochemistry, University of Giessen, D-35392
Giessen, Germany and Department of Immunology and Cell
Biology, Research Center Borstel, D-23845 Borstel, Germany
 |
ABSTRACT |
The isolated
neutral glycosphingolipid fraction from the pig parasitic nematode,
Ascaris suum, was fractionated by silica gel chromatography
to yield a neutral and a zwitterionic glycosphingolipid fraction, the
latter of which mainly contained two zwitterionic glycosphingolipids
termed components A and C. Preliminary chemical characterization with
hydrofluoric acid treatment and immunochemical characterization with a
phosphocholine-specific monoclonal antibody indicated that both
components contained phosphodiester substitutions: phosphocholine for
component A, and phosphocholine and phosphoethanolamine for component
C. Both components were biologically active in inducing human
peripheral blood mononuclear cells to release the inflammatory monokines tumor necrosis factor , interleukin 1, and interleukin 6. Component A was the more bioactive molecule, and its biological activity was abolished on removal of the phosphocholine substituent by
hydrofluoric acid. The glycosphingolipid components were structurally analyzed by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry, liquid secondary ion mass
spectrometry, methylation analysis, 1H NMR spectroscopy,
exoglycosidase cleavage, and ceramide analysis. Their chemical
structures were elucidated to be (see Structure I below),
The carbohydrate
moiety oligosaccharide core was characterized as belonging to the
arthro series of protostomial glycosphingolipids. The ceramide moiety
was distinguished by (R)-2-hydroxytetracosanoic acid as the
dominant fatty acid species and by the C17 iso-branched sphingosine and
sphinganine bases, 15-methylhexadecasphing-4-enine and
15-methylhexadecasphinganine, respectively.
 |
INTRODUCTION |
Analyses of the immunoreactivity
between neutral fraction glycolipids derived from various species of
parasitic nematodes have indicated a high degree of serological
cross-reactivity (1, 2). The structural basis for this immunological
cross-reactivity between parasitic nematodes at the level of
glycolipids is at present unknown. Structural studies on the
neutral fraction glycosphingolipids from adults of the porcine
parasitic nematode Ascaris suum have revealed that the
identified arthro series oligosaccharide chain was not immunogenic,
i.e. did not exhibit immunoreactivity toward infection sera
from A. suum-infected mice (2, 3). However, a zwitterionic
glycosphingolipid fraction was also isolated from A. suum
that demonstrated a phosphodiester sidechain as a structural modification of possibly phosphocholine
(PC)1 and phosphoethanolamine
(PE). In addition, these zwitterionic glycolipids were
immunogenic/antigenic, i.e. exhibited immunoreactivity toward infection sera from A. suum-infected mice (2).
PC-containing macromolecules have been regularly detected in the
extracts of numerous species of parasitic nematodes by immunological means (4-9). Structurally, this moiety has been found bound to N- and O-linked glycans of glycoproteins,
although the exact structure of the PC-oligosaccharide linkage is at
present unknown (10). The biological significance of PC glycans in the
host parasite relationship revolves around their immunomodulatory
activity (11) such that the frequent observation of host T-cell
hyporesponsiveness to filarial nematode infection (12) may involve PC
because of its ability to block T- and B-cell antigen-specific
proliferation (13, 14).
Little is known as to the biological activity of glycolipids, in
general, and parasitic helminth-derived glycolipids, in particular, as
regards their putative modulation of the host immune response via the
cytokine network. Gangliosides have been found to be inhibitory in
terms of cytokine synthesis and release (15), whereas neutral glycosphingolipids of the cestode Echinococcus
multilocularis inhibited the production of interleukin 2 (IL-2)
(16). Because of the physico-chemical similarity between
glycosphingolipids and lipopolysaccharides (LPS) of Gram-negative
bacteria and the induction by the latter of bioactive protein mediators
in the host, i.e. cytokines, responsible for the effects of
endotoxemia (17), a comparative study was performed by Krziwon et
al. (18) on the ability of the former to stimulate the production
of inflammation-associated cytokines. An atypical, zwitterionic
glycosphingolipid (as regards the linkage of the glucuronic acid
residue to the ceramide moiety and the presence of nonacetylated
glucosamine) from the LPS-negative, Gram-negative bacterium
Sphingomonas paucimobilis induced the synthesis and release
of the human mononuclear cell-derived, inflammation-associated cytokines tumor necrosis factor (TNF- ), IL-1, and IL-6 but with
approximately 10,000-fold less activity than LPS, in this respect.
We report here on the structures and biological activity of two
immunoreactive, zwitterionic fraction glycosphingolipids from A. suum in terms of their ability to stimulate the production of the
human mononuclear cell-derived, inflammation-associated cytokines
TNF- , IL-1, and IL-6.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Undamaged, washed adult male and female worms
were collected from the local abattoir and stored at 70 °C until
further use. LPS from Salmonella friedenau was kindly
donated by H. Brade (Borstel Research Institute).
Preparations--
Worms (800 g wet weight) were pulverized at
20 °C in a precooled Waring blendor and lyophilized. Glycolipids
were isolated and purified as described previously (3). In short,
glycolipids were extracted with chloroform/methanol/water 10:10:1 (by
vol), chloroform, methanol, 0.8 M aqueous sodium acetate
30:60:8 (by vol), and 2-propanol, n-hexane, water 55:20:25
(by vol) and evaporated to dryness. To remove most of the contaminating
triglycerides, the residue was treated with acetone at 4 °C for
2 h. Neutral (N-/Nz-) and acidic glycosphingolipids were separated
by DEAE-Sephadex A-25 column chromatography (Pharmacia). The column was
equilibrated with and the sample taken up in chloroform/methanol/water
30:60:8 (by vol). N-/Nz- glycosphingolipids were obtained in the
flow-through, and the acidic glycosphingolipids were eluted with
chloroform, methanol, aqueous 0.8 M sodium acetate 30:60:8
(by vol). Neutral (N-) and zwitterionic (Nz-) glycolipid fractions were
further fractionated on a silica gel60 column (Merck).
Homogeneous, zwitterionic components A and C were obtained by isocratic
elution with chloroform/methanol/water 10:10:2.5 (by vol) from a silica
gel60 column (1 × 50 cm, 70-250 mesh; Merck).
Bioassay Determination of Released Cytokines--
The isolated
Nz-glycosphingolipids, component A and C, and ceramide pentahexoside
(CPH) derived from component A by HF treatment (see below) were
subjected to sterile distilled water dialysis to remove potential cell
culture-perturbing contaminants and traces of organic solvents. After
Speed-Vac lyophilization, the glycosphingolipids were resuspended at 1 mg/ml in sterile distilled water, sonicated, and stored at 20 °C
until further use. As a positive control, S. friedenau-derived LPS was solubilized in pyrogen-free
phosphate-buffered saline at 1 mg/ml, neutralized with triethylamine,
sonicated, and stored at 4 °C until further use.
Human peripheral blood mononuclear cells (PBMC) from healthy donors
were isolated with Ficoll-Paque (Pharmacia) on density gradient
centrifugation. The washed PBMC (106/ml) were cultured in
U-form microtiter plates (Greiner, Nürtingen, Germany) at 200 µl in RPMI 1640 medium containing antibiotics, 10% heat-inactivated
human serum, and the relevant glycolipid. After a 6-h incubation at
37 °C (5% CO2), the supernatants were collected by
centrifugation at 1200 rpm for 5 min and investigated for cytokine
activity.
The supernatants of glycolipid-stimulated PBMC were analyzed by
bioassay as to the cytokine activities of TNF- , IL-1, and IL-6 (19).
The cytotoxicity of TNF- was determined with the TNF-sensitive L929
fibrosarcoma cell line (20). The proliferative capacity of IL-1 was
assayed with human dermal fibroblasts (21). The proliferation of
IL-6-dependent murine B9.9-3A4 hybridoma cells was applied
to determine IL-6 activity.
High Performance Thin-layer Chromatography (HPTLC)--
For
HPTLC separation, HPTLC silica gel60 plates (Merck) were
used. Glycolipids were dissolved at 2 µg/µl in
chloroform/methanol/water 10:10:3 (by vol). For reproducibility, HPTLC
was performed according to Nores et al. (22).
Chloroform/methanol/water 10:10:3 (by vol) was used as the running
solvent. For two-dimensional HPTLC, chloroform, methanol, 2% aqueous
ammonia 10:10:3 (by vol) was employed as the second direction-running
solvent. Glycosphingolipids were visualized using I2 vapor
and/or by spraying the plates with orcinol/sulfuric acid
(carbohydrate-positive compounds) or ninhydrin (free amino groups) and
heating. For immunostaining, the developed HPTLC plates were fixed with
polyisobutylmethylacrylate (Röhm & Haas, Darmstadt, Germany),
blocked with phosphate-buffered saline and bovine serum albumin, and
incubated with the phosphocholine-specific monoclonal antibody TEPC-15
(Sigma) overnight at 4 °C, as described elsewhere (1).
Peroxidase-coupled anti-mouse Ig (Dako Diagnostics, Hamburg, Germany)
was used as the secondary antibody.
Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass
Spectrometry (MALDI-TOF-MS)--
MALDI-TOF-MS data were obtained using
a Vision 2000 instrument (Finnigan MAT, Bremen, Germany) operating in
the positive-ion reflectron and linear modes. Ions were formed by a
pulsed, ultraviolet laser beam (nitrogen laser, = 337 nm). The
matrix used was 2,5-dihydroxybenzoic acid (Sigma) at 10 g/liter in
0.1% aqueous trifluoroacetic acid/acetonitrile 1:2 (by vol).
Liquid Secondary-ion Mass Spectrometry (LSIMS)--
LSIMS was
carried out with a MAT 900 mass spectrometer (Finnigan MAT) equipped
with a cesium gun, which was operated at an emission current of 2-3
µA. Mass spectra were recorded at an acceleration potential of 5 kV
with a resolution of approximately 3,000 and were acquired using a DEC
2100 data system. Spectra of native, peracetylated, or
permethylated glycosphingolipids were recorded in the positive-ion
mode using 3-nitrobenzyl alcohol (Aldrich) as matrix.
NMR Spectroscopy--
The 1H NMR spectra were
recorded at 333 K on a Bruker DRX 600 spectrometer with
deuterium-exchanged samples (0.9 mg each) for solutions in
Me2SO-d6 (99.96%; Aldrich)
containing 2% (by vol) 2H2O (99.96%; Aldrich)
using the 1H signal of dimethyl
sulfoxide-d5 ( H 2.49) as internal
reference. All one- and two-dimensional NMR experiments like
two-dimensional correlation spectroscopy (COSY) and two- and three-step
related coherence transfer (RCT-1 and -2), were performed using
standard Bruker software (XWINNMR, Version 1.3).
HF Treatment--
Nz-glycosphingolipids (native or
permethylated) were dried in a stream of nitrogen and incubated for
24 h at 4 °C with 50-200 µl of HF (48%; Fluka, Neu-Ulm,
Germany). Excess was removed in a stream of nitrogen at room
temperature.
Endoglycoceramidase Cleavage--
Nz-glycosphingolipids were
resuspended in 100 µl of 50 mM sodium acetate buffer, pH
5.0, containing 1 g/liter sodium taurodeoxycholate, and 0.5 milliunits
of endoglycoceramidase (Sigma) were added. After incubation at 37 °C
for 24 h, another 0.5 milliunits of enzyme were added. The
reaction was stopped after 48 h by adding 400 µl of
H2O and 400 µl of water-saturated n-butanol
for phase separation of the reaction products.
Pyridylamination--
Nz-oligosaccharides obtained by
endoglycoceramidase cleavage were reductively pyridylaminated (23) and
the pyridylaminated oligosaccharides were separated by amino-phase
HPLC, as described previously (24).
Exoglycosidase Treatment--
Pyridylaminated oligosaccharides
were cleaved after obligatory HF treatment with either
-D-galactosidase (EC 3.2.1.22) from coffee beans
(Boehringer Mannheim),
N-acetyl- -D-hexosaminidase (EC 3.2.1.52) from
jack beans (Sigma), or -D-mannosidase (EC 3.2.1.25) from
Helix pomatia (Oxford Glycosystems, Abingdon, UK). For
cleavage, the dried oligosaccharides were taken up in 50 µl of 50 mM sodium citrate, pH 4.0, and incubated at 37 °C for
24 h with 50 milliunits of -galactosidase, 166 milliunits of
-N-acetylhexosaminidase, and 25 milliunits of
-mannosidase, respectively.
Methylation Analysis--
Nz-glycosphingolipids (20 µg) were
permethylated both before or after HF treatment and hydrolyzed
(25). Partially methylated alditol acetates obtained after sodium
borohydride reduction and peracetylation were analyzed by capillary
GLC/MS using the instrumentation and microtechniques described
elsewhere (26).
Peracetylation--
Nz-glycosphingolipids were peracetylated
with acetic acid/trifluoroacetic anhydride 1:2 (by vol) for 10 min at
room temperature (27).
Identification of Zwitterionic Substituents--
Phosphocholine
was released by HF treatment of Nz-glycosphingolipid components A and
C. Liberated choline residues were derivatized with
pentafluoropropionic acid anhydride (Supelco, Deisenhofen, Germany) and
analyzed by LSIMS. Ethanolamine was identified as its
9-fluorenylmethoxycarbonyl-derivative by HPLC (28) after HF treatment
of component C.
N-Methylation of Phosphoethanolamine--
Nz-glycosphingolipid
component C was treated with 200 µl of 750 mM aqueous
sodium carbonate containing 20 µl of methyl iodide for 2 h at
50 °C (29, 30), and thereafter, desalted on a reverse-phase cartridge (31).
Ceramide Analysis--
For fatty acid analysis,
Nz-glycosphingolipids (1-10 nmol) were hydrolyzed according to Gaver
and Sweeley (32). The resultant fatty acid methyl esters were analyzed
by capillary GLC/MS using the instrumentation described previously
(26). For the separation of fatty acid species, a fused silica
capillary column (DB1, 0.25 mm internal diameter, 60 m; ICT, Bad
Homburg, Germany) was used. The column temperature was increased from
80 °C at 7 °C/min to a final temperature of 320 °C and held
isothermally for 10 min. Spectra were recorded either after chemical
ionization (CI-MS) with ammonia or electron-impact ionization (EI-MS)
at an electron energy of 2.4033 × 10 17 J or
1.1215 × 10 17 J, respectively. For determination of
the absolute configuration at C-2 of the contained hydroxy fatty acids,
they were converted to the corresponding
(R)-phenylethylamides and trifluoroacetylated as described
previously (3). Sphingoid bases were analyzed after conversion to the
corresponding fatty acids by periodate and periodate/permanganate
oxidation as their methyl and picolinyl esters as described elsewhere
(3).
 |
RESULTS |
Isolation of Zwitterionic Components A and
C--
Glycosphingolipids were separated into a neutral and acidic
fraction by anion-exchange column chromatography. Two-dimensional HPTLC
of the resultant neutral fraction indicated the presence of two groups
of glycosphingolipids: N-neutral, Nz-neutral
zwitterionic glycosphingolipids (see Fig.
1). For isolation of the two main zwitterionic components A and C, the neutral
fraction was subfractionated into a neutral and neutral zwitterionic
fraction by silica gel column chromatography. A further silica gel
column chromatography yielded four fractions designed as components A,
B1, B2, and C. The fractions B1 and B2 represent nonhomogeneous, minor
zwitterionic components and will not be discussed further in this
publication.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 1.
Two-dimensional HPTLC separation of N- and
Nz-glycosphingolipids of A. suum. HPTLC separation was
performed on silica gel60 plates. The solvents used were
chloroform/methanol/water 10:10:3 (by vol) for the first dimension and
chloroform, methanol, 2% aqueous ammonia 10:10:3 (by vol) for the
second dimension. Glycosphingolipids were detected by spraying the
plate with orcinol/sulfuric acid. Components A and C are indicated by
arrows.
|
|
Chemical and Immunochemical Characterization--
The two
zwitterionic components A and C were separated on HPTLC by
chloroform/methanol/water 10:10:3 (by vol) as running solvent. Both
components gave positive reactions on incubation with iodine vapor,
spraying with orcinol/sulfuric acid, and molybdate reagent (organic
phosphate groups). HPTLC-immunostaining with the
phosphocholine-specific monoclonal antibody TEPC-15 is shown in Fig.
2. Due to the approximately 50-fold higher sensitivity
of HPTLC-immunostaining, additional, minor species of components A and
C resulting from heterogeneities in their lipid moieties were also
visualized. The component C also reacted with ninhydrin, indicating the
presence of a free amino group. HF treatment of the zwitterionic
compounds yielded glycosphingolipids with migration properties on HPTLC
similar to CPH, which showed no reaction with TEPC-15 or ninhydrin.
Choline was identified after HF treatment of the components A and C by derivatization with pentafluoropropionic acid anhydride and analysis by
LSIMS, yielding a molecular ion [M]+ at
m/z 250. Ethanolamine was identified after HF
treatment of compound C as its 9-fluorenylmethoxycarbonyl derivative by
HPLC and co-chromatography with the standard (data not shown).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 2.
Chemical and immunochemical characterization
of HPTLC-resolved, zwitterionic components A and C. Zwitterionic
components A and C were separated on silica gel60 HPTLC
plates with chloroform/methanol/water 10:10:3 (by vol) as running
solvent. Glycosphingolipids were detected chemically by spraying with
orcinol/sulfuric acid (a) or ninhydrin (b) and
immunochemically by staining with the phosphocholine-specific monoclonal antibody TEPC-15 (c).
|
|
Zwitterionic Component A- and C-induced Monokine
Production--
Since we consider A. suum merely as a model
for the human parasitic nematode Ascaris lumbricoides, all
in vitro procedures were performed with human and not
porcine PBMC. The zwitterionic components A and C and the component
A-derived CPH were assayed as to their biological activity in inducing
the inflammatory monokines TNF- , IL-1, and IL-6 because of the
postulated similarities in physico-chemical properties and biological
activity between glycosphingolipids and LPS. Components A and C, but
not ceramide pentasaccharide, were shown to be biologically active in
terms of a dose-dependant response in the release of TNF- , IL-1,
and IL-6 (see Fig. 3). For IL-1 and IL-6,
this dose dependence of cytokine release was evident up to and
including 1000 ng/ml component A, with the apparent presumption that
higher concentrations were inhibitory at the cellular level. Of the two
zwitterionic glycolipids tested, component A was the more bioactive in
inducing the monokines TNF- and IL-1; component A and to a lesser
extent component C were also capable of inducing low levels of IL-6
activity as demonstrated in three separate experiments (data not
shown). The apparent inconsistency in concentration levels measured was
due to the inherent between-experiment variability of the bioassay
system with different human donors.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 3.
Zwitterionic component A- and C-induced
monokine production by human PBMC. PBMC (106/ml) were
cultured for 6 h with varying concentrations of the glycosphingolipid components A, C, and CPH, and positive
control LPS (1-10,000 ng/ml). After incubation, supernatants were
collected, and their TNF- , IL-1, and IL-6 activities determined by
bioassay.
|
|
Structural Analysis of Zwitterionic Components A and C--
For
structural analysis, the zwitterionic components A and C were subjected
to MALDI-TOF-MS, LSIMS, methylation analysis, and exoglycosidase
digestion. The results of MALDI-TOF-MS and LSIMS are summarized in
Table I and methylation data in Table II.
View this table:
[in this window]
[in a new window]
|
Table I
Analysis of zwitterionic glycosphingolipids A and C from A. suum by
MALDI-TOF-MS and LSIMS
Glycolipids were analyzed in native, permethylated, or peracetylated
form by MALDI-TOF-MS and LSIMS. For MALDI-TOF-MS, native glycolipids
were dissolved in chloroform/methanol/water 10:10:3 (by vol), and
2,5-dihydroxybenzoic acid was used as matrix. For LSIMS, native
compounds or permethylated, and peracetylated glycolipids were
dissolved in chloroform/methanol/water 10:10:3 (by vol) or dichloromethane, respectively, and applied to a matrix of 3-nitrobenzyl alcohol. /+ HF, before/after HF-treatment. Calculated masses are
based on monoisotopic masses.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Methylation analysis of zwitterionic glycosphingolipids A and C
A. suum Nz-glycosphingolipids were treated according to the
following sequence: with (C3) or without (A1, A2, C1, C2)
PE-methylation, with (A1, C1) or without (A2, C2, C3) HF treatment
before permethylation, with (A2, C2, C3) or without (A1, C1) HF
treatment after permethylation. The partially methylated sugar
derivatives obtained after reduction and peracetylation were analyzed
by capillary GLC/MS. Results are expressed as peak ratios of the
alditol acetates found based on 2,3,6-GlcOH = 1.0. The low yields
of terminal monosaccharides are due to their higher volatility, i.e. a
higher level of methylation. Due to a lower sensitivity for
N-acetylhexosamines, their presence or absence is indicated
by +/ . 2,3,4,6-GlcOH, 2,3,4,6-tetra-O-methylglucitol; 3,4,6-GlcN(Me)AcOH,
2-deoxy-2-(N-methyl)acetamido-3,4,6-tri-O-methylglucitol, etc.
|
|
Positive-ion MALDI-TOF-MS analysis in the linear mode of the
zwitterionic compounds A and C revealed pseudomolecular ions at
m/z 1732 ([M + Na]+) and 1833 ([M + H]+), respectively, whereas in the reflectron mode,
pseudomolecular ions at m/z 1669 ([{M 87}+ 2Na + H]+; loss of choline) and 1813 ([{M 45} + Na + 2H]+, loss of ethanolamine) were
respectively observed (see Fig. 4 and
Table I), due to metastable decay. After HF treatment, a pseudomolecular ion ([M + Na]+) at
m/z 1568 was measured in linear and reflectron
mode for components A and C, indicating a homologous glycolipid
backbone with the composition Hex3HexNAc2-Cer
corresponding to component CPH of the neutral glycolipid fraction of
A. suum (3).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 4.
MALDI-TOF-MS analysis of zwitterionic
components A and C. Native zwitterionic glycosphingolipid
components A (a-d) and C (e-g) were analyzed by
MALDI-TOF-MS in positive-ion linear (b, d, and
f) and reflectron (a, c, e,
and g) modes either before (a, b,
e, and f) or after HF-treatment (c,
d, and g) with 2,5-dihydroxybenzoic acid as
matrix. Pseudomolecular ions are given in accurate mass values rounded
to the nearest mass unit. a, [M + Na]+;
b, [M + H]+; c, [(M 87) + 2Na + H]+; d, [(M 87) + Na + Li + H]+; f, [(M 45) + Na + 2H]+.
Inset in a, after LiCl addition.
|
|
Positive-ion LSIMS of the native zwitterionic compounds A and C
revealed pseudomolecular ions at m/z 1710, 1712 ([M + H]+) and 1833 ([M + H]+),
respectively (see Table I). After permethylation, pseudomolecular ions
at m/z 1899 ([{M 87} + Na + 2H]+; loss of choline) were observed for both compounds
due to the loss of the phosphoethanolamine substituent in component C
during the permethylation procedure; the addition of sodium acetate
shifted the pseudomolecular ions ([{M 87} + 2Na + H]+) to m/z 1921, 1923. Pseudomolecular ions ([M + H]+) at
m/z 2340, 2342 and m/z
2463, 2465 were, respectively, observed after peracetylation of the two
zwitterionic compounds (see Fig. 5),
whereas pseudomolecular ions at m/z 2298, 2300 and 2379, 2381 and 2421, 2423, respectively, are most likely due to
incomplete acetylation and/or ketene elimination.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 5.
LSIMS of peracetylated zwitterionic
components A and C. Peracetylated zwitterionic glycosphingolipid
components A (a) and C (b) were analyzed by LSIMS
in the positive-ion mode using 3-nitrobenzyl alcohol as matrix. The [M + H]+ pseudomolecular ions registered are given in
accurate mass values rounded to the nearest mass unit.
Numbers in parentheses mark pseudomolecular
ions, probably resulting from incomplete acetylation and/or ketene
elimination.
|
|
To locate the monosaccharide linkage and phosphodiester substitution
positions, methylation analysis of the two zwitterionic compounds A
and C was performed with the permethylation procedures both before
or after HF treatment (Table II). If the permethylation procedure was
performed after HF treatment, the compounds A and C showed similar
results with terminal galactose, 3-substituted mannose, 4-substituted
glucose, 4-substituted N-acetylglucosamine, and
3-substituted N-acetylgalactosamine (Table II, columns A1 and C1). HF treatment after the permethylation procedure revealed for
compound A the presence of a 4,6-disubstituted
N-acetylglucosamine (Table II, column A2) that indicated
location of the phosphocholine substituent at the C-6 of
N-acetylglucosamine. For compound C, a 4,6-disubstituted
N-acetylglucosamine and a 3,6-disubstituted mannose were
found along with 3-substituted mannose (Table II, column C2), the
latter of which is formed due to the lability of the
phosphoethanolamine substituent to the conditions of the permethylation procedure (33). If the phosphoethanolamine substituent was stabilized by methylation to choline before permethylation, the
major mannose constituent was found to be 3,6-disubstituted mannose,
indicating the localization of phosphoethanolamine at the C-6 of
mannose (Table II, column C3).
The zwitterionic glycolipids were cleaved by endoglycoceramidase,
and the liberated oligosaccharides were reductively pyridylaminated and
isolated by amino-phase HPLC. For determination of the anomeric configurations of individual glycosidic bonds, pyridylaminated oligosaccharides, after HF-treatment, were sequentially incubated with
-galactosidase, -N-acetylhexosaminidase, and
-mannosidase, resulting in the release of one galactosyl residue,
two N-acetylhexosaminyl residues, and one mannosyl residue,
as confirmed by amino-phase HPLC.
As a second method for structural confirmation, the anomeric linkages
of the sugar residues in components A and C were further elucidated by
1H NMR spectroscopy as -GalV,
-GalNAcIV, -GlcNAcIII,
-ManII, and -GlcI (Table
III). Chemical shift values and coupling
constants (3J1,2) of the anomeric
protons were found to be very similar, indicating identical linkages
and composition in both glycosphingolipids. With the exception of the
terminal -Gal residue, all sugars were identified to express
-anomeric linkage. The anomeric linkage of the ManII
could not be determined by a one-dimensional 1H NMR
experiment but was investigated following the connectivities of the
spin system using two-dimensional correlation spectroscopy (COSY) and
two- and three-step-related coherence transfer (RCT-1 and -2) (data not
shown). All anomeric linkages determined by 1H NMR were
found to be identical as compared with results obtained by enzymatic
degradation reactions (see above).
View this table:
[in this window]
[in a new window]
|
Table III
600-MHz 1H NMR data of anomeric protons (H-1) for compounds A
and C
Chemical shifts ( ) are given in parts/million in dimethyl
sulfoxide-d6 at 333 K; coupling constants
(3J1,2) are given in hertz.
|
|
In addition, glycosphingolipids A and C showed characteristic singlets
(integral 9H) for the methyl protons of the choline residue
[-+N(CH3)3] (3.135 ppm, compound A; 3.156 ppm, compound C) originating from a
phosphocholine residue being assigned by methylation analysis to
position 6 of the GlcNAcIII residue in both
glycosphingolipids.
For ceramide analysis, the two zwitterionic glycolipids were subjected
to acid hydrolysis according to Gaver and Sweeley (32). Fatty acids
were extracted with n-hexane and analyzed by GLC/MS. In
agreement with previous data on neutral A. suum
glycosphingolipids (see Table III and Fig. 4 in Ref. 3), the results
demonstrated the predominant presence of 2-hydroxytetracosanoic acid.
The absolute configuration at C-2 was found to be (R) by
GLC/MS analysis of the corresponding trifluoroacetylated
(R)-phenylethylamide (data not shown). Sphingoid bases were
analyzed after periodate and periodate/permanganate oxidation as their
methyl and picolinyl esters (data not shown). The results indicated the
presence of C17 iso-branched sphingosine and sphinganine bases in
agreement with Ref. 3.
 |
DISCUSSION |
A slowly emerging chemical characteristic of invertebrate
glycoconjugates (glycolipids, glycoproteins) is their frequent
substitution by electrically neutral but amphoteric moieties. The
diversity of zwitterionic glycoconjugates among the various phyla of
the Invertebrata would point to their biological importance, but as yet, unknown functional significance. A major post-translational modification of parasitic helminth antigens is apparently PC. This
antigenic determinant has been detected in nematodes (5, 8, 34, 35), in
trematodes, including Schistosoma mansoni (9), and in the
cestode Bothriocephalus scorpii (36). In fact, the frequency
of serological cross-reactivity between cestodes, trematodes and, in
particular, nematodes (37) may be accounted for by the broad
distribution of PC-bearing molecules. The (macro)molecular location of
the PC moiety is in most cases unknown, but at least in the
excretory/secretory product (ES-62) of the adult filarial nematode,
Acanthocheilonema viteae, it is attached to the protein backbone via an N-linked glycan (38).
Zwitterionic glycosphingolipids have been structurally
characterized from various members of the invertebrate phyla, including identification of the monosaccharide-amphoteric moiety in the Sarcomastigophora (Flagellata) as Man-phosphoethanolamine (39), in the
Annelida as Gal-phosphocholine (40-44), in the Arthropoda (Crustacea)
as Glc-phosphonoethanolamine (45), in the Arthropoda (Insecta) as
GlcNAc-phosphoethanolamine (33, 46, 47), in the Mollusca (freshwater
Bivalvia) as Man-phosphoethanolamine (48), in the Mollusca (marine
Gastropoda) as Gal-phosphonoethanolamine (49, 50), and in the Nematoda
(Ascaridida) as GlcNAc-phosphocholine and Man-phosphoethanolamine (Ref.
3 and this publication).
Localization of zwitterionic substituents such as phosphocholine or
phosphoethanolamine was performed by HF treatment, both before or after
permethylation and subsequent hydrolysis, reduction, and peracetylation
(in the range of 10 µg of glycosphingolipid). The alkali instability
of the phosphoethanolamine substituent, however, requires selective
N-methylation before the permethylation procedure.
MALDI-TOF-MS analysis of the zwitterionic glycolipids revealed a
characteristic fragmentation in the reflectron mode, probably due to
the loss of choline (M 87) and ethanolamine (M-45),
respectively, by metastable decay, which was not detectable in the
linear mode. A similar fragmentation pattern has been observed in LSIMS
after permethylation, whereas the peracetylated structures were found
to be stable. This idiosyncratic fragmentation behavior may help to
detect and identify zwitterionic substituents by mass spectrometry.
Structural elucidation of the two major, zwitterionic
glycosphingolipids (components A and C) of the porcine, parasitic
nematode A. suum has shown their common pentasaccharide core
to belong to the arthro-carbohydrate series (as originally isolated
from glycosphingolipids of the blowflies Calliphora vicina
and Lucilia caesar). The amphoteric substituent PC is linked
to C-6 of the third monosaccharide in the oligosaccharide chain,
GlcNAc, of component A, and, uniquely, the amphoteric substituents PE
and PC are simultaneously linked to C-6 of the second and the third monosaccharide in the oligosaccharide chain, Man and GlcNAc,
respectively, in component C. Component C, therefore, represents the
first member of the glycosphingolipids to carry two zwitterionic
substituents. The carbohydrate and ceramide moieties of the two
zwitterionic glycosphingolipids correspond to the recently elucidated
arthropentaosyl ceramide of A. suum. (3) Therefore, we have
assumed that the biosynthetic pathway of the former involves
zwitterionic substitution of the latter, either at the level of CPH or
incomplete oligosaccharide cores.
The 1H-NMR data obtained for both glycosphingolipids A and
C were found to be structurally closely related to that identified in a
pentaglycosyl phosphoglycosphingolipid (Nz5a) isolated from the blowfly
C. vicina Meigen (51). Comparing the glycosphingolipid Nz5a
of the blowfly C. vicina Meigen and compound A described here, both belong to the arthro series, and only three structural differences were observed: (i) a terminal -GalNAcV
instead of -GalV, (ii) the terminal sugar
( -GalNAcV) being (1 4)-linked in Nz5a and
-GalV being (1 3)-linked in compound A, and (iii)
2-aminoethyl phosphate instead of a phosphocholine substituent in
position 6 of GlcNAcIII. The biological properties of
the glycosphingolipid Nz5a, however, were not investigated.
Glycosphingolipids have been shown to be immunomodulatory molecules
that suppress cells of the immune system, both in vivo and
in vitro. Thus, gangliosides inhibit the in vitro
proliferative response of various classes of activated immune cells
such as T- and B-lymphocytes, macrophages, and natural killer cells
(52). However, the molecular mechanism(s) underlying the
immunosuppressive activity of glycosphingolipids are incompletely
understood but include the direct interaction of ganglioside micelles
with IL-2 and IL-4 in the modulation of
IL-2-/IL-4-dependent processes (53) and the interference of
monocytes at the level of antigen presentation (54). The
immunomodulation of T-lymphocyte activation in vivo and
in vitro, observed in the case of Trypanosoma
cruzi glycoinositol phospholipids, can be directly related to the
ceramide moiety of the molecule (55). A functional resemblance of LPS
to glycosphingolipids has been proposed and reinforced by the ability
of the former to mimic the second messenger ceramide in TNF- - and
IL-1-stimulated cells (56, 57). Since there is no structural similarity
between these two classes of lipid molecules, it may be assumed that
this coincidence of biological activity is based on similar
physico-chemical properties. The ability of A. suum
zwitterionic components A and C to induce the human PBMC inflammatory
cytokines of TNF- , IL-1, and IL-6 provides a further example for the
parallelism between LPS and glycosphingolipid biological activity.
Interestingly, the zwitterionic glycosphingolipids of A. suum stimulated rather than suppressed human PBMC production of
the cytokines TNF- and IL-6 in a concentration range similar to that of LPS stimulation, whereas these molecules were at least a factor 100-fold less potent than LPS in the stimulation of IL-1. In general, component C was less active than component A. When compared with LPS
with respect to the amount of cytokine induced, component A was as
active in the stimulation of TNF- but was decreasingly active in the
sequence of IL-1 and IL-6. The expression of the inflammatory response
cytokines TNF- , IL-1, and IL-6 is usually considered to be
concomitant (58). Until concrete data are available, there are at least
two plausible explanations for the detection of the anomalous,
nonconcomitant levels of these cytokines induced by the A. suum-derived zwitterionic glycosphingolipids under study. First,
kinetic studies of LPS- and zwitterionic glycosphingolipid-induced inflammatory cytokine expression demonstrated maximal activity in the
temporal sequence of TNF- and IL-1 at approximately the same time
point and prior to that of IL-6 (18, 19). The fixed-point determination
of cytokine release in the assay used in this study at 8 h of
incubation introduces an experimental artifact whereby TNF- and IL-1
approach their maximal levels of activity, whereas IL-6 induction is
suboptimal at this time point. Secondly, it is known that activation of
monocytes by LPS is a receptor-mediated process that is transduced by
the cell surface molecule CD 14 (59). The mechanism by which the
A. suum-derived zwitterionic glycosphingolipids induce
cytokine production is, however, unknown. It may be postulated that
they act in a direct way by replacing intracellular lipid second
messengers such as ceramide. Therefore, a different pattern of
cytokines released by activated monocytes may be due to different
mechanisms of activation.
 |
ACKNOWLEDGEMENTS |
The authors wish to express special
recognition to Ina Goroncy, Borstel Research Institute, Department of
Immunology and Cell Biology for the implementation and ultimate success
of the monokine bioassay experiments. We also thank Peter Kaese, Werner
Mink, and Siegfried Kühnhardt for methylation, GLC/MS, and LSIMS
analyses and Ulrich Zähringer (Department of Immunochemistry,
Research Center Borstel, Borstel) for performing the NMR analysis.
 |
FOOTNOTES |
*
This project was supported by the Deutsche
Forschungsgemeinschaft (SFB 535 and Graduiertenkolleg Molecular Biology
and Pharmacology) and by the Bundesministerium für Bildung,
Wissenschaft, Forschung und Technologie Grant 01 KI 9471.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Biochemisches Institut
am Klinikum der Universität, Friedrichstrasse 24, D-35392 Giessen, Germany. Tel.: +49-641-99-47400; Fax: +49-641-99-47409; E-mail: Rudolf.Geyer{at}biochemie.med.uni-giessen.de.
1
The abbreviations used are: PC, phosphocholine;
PE, phosphoethanolamine; CPH, ceramide pentahexoside; HPTLC,
high-performance thin-layer chromatography; IL, interleukin; LPS,
lipopolysaccharide; LSIMS, liquid secondary-ion mass spectrometry;
MALDI-TOF-MS, matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry; N-glycolipid, neutral glycolipid;
Nz-glycolipid, zwitterionic glycolipid; PBMC, peripheral blood
mononuclear cells; TNF, tumor necrosis factor; HPLC, high performance
liquid chromatography; GLC, gas-liquid chromatography; Hex, hexose;
HexNAc, N-acetylhexosamine.
 |
REFERENCES |
-
Baumeister, S.,
Dennis, R. D.,
Klünder, R.,
Schares, G.,
Zahner, H.,
and Geyer, E.
(1994)
Parasite Immunol. (Oxf.)
16,
629-641
-
Dennis, R. D.,
Baumeister, S.,
Smuda, C.,
Lochnit, G.,
Waider, T.,
and Geyer, E.
(1995)
Parasitology
110,
611-623
-
Lochnit, G.,
Dennis, R. D.,
Zähringer, U.,
and Geyer, R.
(1997)
Glycoconj. J.
14,
389-399[CrossRef][Medline]
[Order article via Infotrieve]
-
Crandall, C. A.,
and Crandall, R. B.
(1971)
Exp. Parasitol.
30,
426-437[CrossRef][Medline]
[Order article via Infotrieve]
-
Pery, P.,
Petit, A.,
Poulain, J.,
and Luffau, G.
(1974)
Eur. J. Immunol.
4,
637-639[Medline]
[Order article via Infotrieve]
-
Brown, A. R.,
and Crandall, C. A.
(1976)
J. Immunol.
116,
1105-1109[Abstract/Free Full Text]
-
Mitchell, G. F.,
Hogarth-Scott, R. S.,
Edwards, R. D.,
Lewers, H. M.,
Cousins, G.,
Moorem, T.
(1976)
Int. Arch. Allergy Appl. Immunol.
52,
64-78[Medline]
[Order article via Infotrieve]
-
Gutman, G. A.,
and Mitchell, G. F.
(1977)
Exp. Parasitol.
43,
161-168[CrossRef][Medline]
[Order article via Infotrieve]
-
Pery, P.,
Luffau, G.,
Charley, J.,
Petit, A.,
Rouze, P.,
and Bernard, S.
(1979)
Ann. Immunol. (Inst. Pasteur)
130C,
889-900[Medline]
[Order article via Infotrieve]
-
Harnett, W.,
Houston, K. M.,
Amess, R.,
and Worms, M. J.
(1993)
Exp. Parasitol.
77,
498-502[CrossRef][Medline]
[Order article via Infotrieve]
-
Mitchell, G. F.,
and Lewers, H. M.
(1976)
Int. Arch. Allergy Appl. Immunol.
52,
235-240[Medline]
[Order article via Infotrieve]
-
Allen, J. E.,
Lawrence, R. A.,
and Maizels, R. M.
(1996)
Int. Immunol.
8,
143-151[Abstract/Free Full Text]
-
Lal, R. B.,
Kumaraswami, V.,
Steel, C.,
and Nutman, T. B.
(1990)
Am. J. Trop. Med. Hyg.
42,
56-64
-
Harnett, W.,
and Harnett, M. M.
(1993)
J. Immunol.
151,
4829-4837[Abstract]
-
Ziegler-Heitbrock, H. W. L.,
Käfferlein, E.,
Haas, J. G.,
Meyer, N.,
Ströbel, M.,
Weber, C.,
Flieger, D.
(1992)
J. Immunol.
148,
1753-1758[Abstract]
-
Persat, F.,
Vincent, C.,
Schmitt, D.,
and Mojon, M.
(1996)
Infect. Immun.
64,
3682-3687[Abstract]
-
Rietschel, E. T.,
Brade, H.,
Holst, O.,
Brade, L.,
Müller-Loennies, S.,
Mamat, U.,
Zähringer, U.,
Beckmann, F.,
Seydel, U.,
Brandenburg, K.,
Ulmer, A. J.,
Mattern, T.,
Heine, H.,
Schletter, J.,
Loppnow, H.,
Schönbeck, U.,
Flad, H. D.,
Hauschildt, S.,
Schade, U. F.,
Padova, F. D.,
Kusumoto, S.,
Schumann, R. R.
(1996)
Curr. Top. Microbiol. Immunol.
216,
40-81
-
Krziwon, C.,
Zähringer, U.,
Kawahara, K.,
Weidemann, B.,
Kusumoto, S.,
Rietschel, E. T.,
Flad, H. D.,
Ulmer, A. J.
(1995)
Infect. Immun.
63,
2899-2905[Abstract]
-
Feist, W.,
Ulmer, A. J.,
Wang, M. H.,
Musehold, J.,
Schlüter, C.,
Gerdes, J.,
Herzbeck, H.,
Brade, H.,
Kusumoto, S.,
Diamantstein, T.,
Rietschel, E. T.,
Flad, H. D.
(1992)
FEMS Microbiol. Immunol.
89,
73-90[CrossRef]
-
Feist, W.,
Ulmer, A. J.,
Musehold, J.,
Brade, H.,
Kusumoto, S.,
and Flad, H. D.
(1989)
Immunobiology
179,
293-307[Medline]
[Order article via Infotrieve]
-
Loppnow, H.,
Flad, H. D.,
Dürrbaum, I.,
Musehold, J.,
Fetting, R.,
Ulmer, A. J.,
Herzbeck, H.,
Brandt, E.
(1989)
Immunobiology
179,
283-291[Medline]
[Order article via Infotrieve]
-
Nores, G. A.,
Mizutamari, R. K.,
and Kremer, D. M.
(1994)
J. Chromatogr. A
686,
155-157[CrossRef]
-
Kondo, A.,
Suzuki, J.,
Kuraya, N.,
Hase, S.,
Kato, I.,
and Ikenaka, T.
(1990)
Agric. Biol. Chem.
54,
368-369
-
Lochnit, G.,
and Geyer, R.
(1995)
Eur. J. Biochem.
228,
805-816[Medline]
[Order article via Infotrieve]
-
Paz-Parente, J.,
Cardon, P.,
Leroy, Y.,
Montreuil, J.,
Fournet, B.,
and Ricard, G.
(1985)
Carbohydr. Res.
141,
41-47[CrossRef][Medline]
[Order article via Infotrieve]
-
Geyer, R.,
and Geyer, H.
(1994)
Methods Enzymol.
230,
86-108[Medline]
[Order article via Infotrieve]
-
Dell, A.
(1990)
Methods Enzymol.
193,
647-660[Medline]
[Order article via Infotrieve]
-
Hensel, J.,
Hintz, M.,
Karas, M.,
Linder, D.,
Stahl, B.,
and Geyer, R.
(1995)
Eur. J. Biochem.
232,
373-380[Medline]
[Order article via Infotrieve]
-
Höltje, J. V.,
and Tomasz, A.
(1975)
Proc. Natl. Acad. Sci. U. S. A.
72,
1690-1694[Abstract/Free Full Text]
-
Höltje, J. V.,
and Tomasz, A.
(1975)
J. Biol. Chem.
250,
6072-6076[Abstract/Free Full Text]
-
Williams, M. A.,
and McCluer, R. H.
(1980)
J. Neurochem.
35,
266-269[Medline]
[Order article via Infotrieve]
-
Gaver, R. C.,
and Sweeley, C. C.
(1965)
J. Am. Oil Chem. Soc.
42,
294-298
-
Helling, F.,
Dennis, R. D.,
Weske, B.,
Nores, G.,
Peter-Katalinic, J.,
Dabrowski, U.,
Egge, H.,
and Wiegandt, H.
(1991)
Eur. J. Biochem.
200,
409-421[Medline]
[Order article via Infotrieve]
-
Gualzata, M.,
Weiss, N.,
and Heusser, C. H.
(1986)
Exp. Parasitol.
61,
95-102[CrossRef][Medline]
[Order article via Infotrieve]
-
Lal, R. B.,
Paranjape, R. S.,
Briles, D. E.,
Nutman, T. B.,
Ottesen, E. A.
(1987)
J. Immunol.
138,
3454-3460[Abstract]
-
Fletcher, T. C.,
White, A.,
and Baldo, B. A.
(1980)
Parasite Immunol. (Oxf.)
2,
237-248
-
Maizels, R. M.,
and Selkirk, M.
(1988)
in
The Biology of Parasitism (Englund, P. T., and Sher, A. E., eds), pp. 285-308, Alan R. Liss, New York
-
Houston, K. M.,
and Harnett, W.
(1996)
J. Parasitol.
82,
320-324[CrossRef][Medline]
[Order article via Infotrieve]
-
Winter, G.,
Fuchs, M.,
McConville, M. J.,
Stierhof, Y. D.,
Overath, P.
(1994)
J. Cell Sci.
107,
2471-2482[Abstract]
-
Noda, N.,
Tanaka, R.,
Miyahara, K.,
and Kawasaki, T.
(1992)
Tetrahedron Lett.
33,
7527-7530[CrossRef]
-
Noda, N.,
Tanaka, R.,
Miyahara, K.,
and Kawasaki, T.
(1993)
Chem. Pharm. Bull. (Tokyo)
41,
1733-1737
-
Noda, N.,
Tanaka, R.,
Miyahara, K.,
and Kawasaki, T.
(1993)
Biochim. Biophys. Acta
1169,
30-38[Medline]
[Order article via Infotrieve]
-
Sugita, M.,
Fuji, H.,
Inagaki, F.,
Suzuki, M.,
Hayata, C.,
and Hori, T.
(1992)
J. Biol. Chem.
267,
22595-22598[Abstract/Free Full Text]
-
Sugita, M.,
Fujii, H.,
Dulaney, J. T.,
Inagaki, F.,
Suzuki, M.,
Suzuki, A.,
Ohta, S.
(1995)
Biochim. Biophys. Acta
1259,
220-226[Medline]
[Order article via Infotrieve]
-
Itonori, S.,
Kamemura, K.,
Narushima, K.,
Sonku, N.,
Itasaka, O.,
Hori, T.,
and Sugita, M.
(1991)
Biochim. Biophys. Acta
1081,
321-327[Medline]
[Order article via Infotrieve]
-
Weske, B.,
Dennis, R. D.,
Helling, F.,
Keller, M.,
Nores, G. A.,
Peter-Katalinic, J.,
Egge, H.,
Dabrowski, U.,
Wiegandt, H.
(1990)
Eur. J. Biochem.
191,
379-388[Medline]
[Order article via Infotrieve]
-
Itonori, S.,
Nishizawa, M.,
Suzuki, M.,
Inagaki, F.,
Hori, T.,
and Sugita, M.
(1991)
J. Biochem. (Tokyo)
110,
479-485[Abstract/Free Full Text]
-
Itasaka, O.,
and Hori, T.
(1979)
J. Biochem. (Tokyo)
85,
1469-1481[Abstract/Free Full Text]
-
Araki, S.,
Abe, S.,
Odani, S.,
Ando, S.,
Fujii, N.,
and Satake, M.
(1987)
J. Biol. Chem.
262,
14141-14145[Abstract/Free Full Text]
-
Araki, S.,
Abe, S.,
Ando, S.,
Fuji, N.,
and Satake, M.
(1987)
J. Biochem. (Tokyo)
101,
145-152[Abstract/Free Full Text]
-
Dabrowski, U.,
Dabrowski, J.,
Helling, F.,
and Wiegandt, H.
(1990)
J. Biol. Chem.
265,
9737-9743[Abstract/Free Full Text]
-
Dyatlovitskaya, E. V.,
and Bergelson, L. D.
(1987)
Biochim. Biophys. Acta
907,
125-143[Medline]
[Order article via Infotrieve]
-
Chu, J. W. K.,
and Sharom, F. J.
(1995)
Immunology
84,
396-403[Medline]
[Order article via Infotrieve]
-
Heitger, A.,
and Ladisch, S.
(1996)
Biochim. Biophys. Acta
1303,
161-168[Medline]
[Order article via Infotrieve]
-
Gomes, N. A.,
Previato, J. O.,
Zingales, B.,
Mendonca-Previato, L.,
and DosReis, G. A.
(1996)
J. Immunol.
156,
628-635[Abstract]
-
Joseph, C. K.,
Wright, S. D.,
Bornmann, W. G.,
Randolph, J. T.,
Kumar, E. R.,
Bittman, R.,
Liu, J.,
Kolesnik, R. N.
(1994)
J. Biol. Chem.
269,
17606-17610[Abstract/Free Full Text]
-
Wright, S. D.,
and Kolesnik, R. N.
(1995)
Immunol. Today
16,
297-302[CrossRef][Medline]
[Order article via Infotrieve]
-
Kuby, J.
(1992)
Immunology, pp. 245-270, W. H. Freeman and Co., New York
-
Gegner, J. A.,
Ulevitch, R. J.,
and Tobias, P. S.
(1995)
J. Biol. Chem.
270,
5320-5325[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. D. Fuller, T. Schwientek, H. H. Wandall, J. W. Pedersen, H. Clausen, and S. B. Levery
Structure elucidation of neutral, di-, tri-, and tetraglycosylceramides from High Five cells: identification of a novel (non-arthro-series) glycosphingolipid pathway
Glycobiology,
December 1, 2005;
15(12):
1286 - 1301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Meyer, E. van Liempt, A. Imberty, Y. van Kooyk, H. Geyer, R. Geyer, and I. van Die
DC-SIGN Mediates Binding of Dendritic Cells to Authentic Pseudo-LewisY Glycolipids of Schistosoma mansoni Cercariae, the First Parasite-specific Ligand of DC-SIGN
J. Biol. Chem.,
November 11, 2005;
280(45):
37349 - 37359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pingoud, A. Sudina, H. Geyer, J. M. Bujnicki, R. Lurz, G. Luder, R. Morgan, E. Kubareva, and A. Pingoud
Specificity Changes in the Evolution of Type II Restriction Endonucleases: A BIOCHEMICAL AND BIOINFORMATIC ANALYSIS OF RESTRICTION ENZYMES THAT RECOGNIZE UNRELATED SEQUENCES
J. Biol. Chem.,
February 11, 2005;
280(6):
4289 - 4298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Geyer, R. Geyer, and V. Pingoud
A novel strategy for the identification of protein-DNA contacts by photocrosslinking and mass spectrometry
Nucleic Acids Res.,
September 21, 2004;
32(16):
e132 - e132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wuhrer, C. Grimm, U. Zahringer, R. D. Dennis, C. M. Berkefeld, M. A. Idris, and R. Geyer
A novel GlcNAc{alpha}1-HPO3-6Gal(1-1)ceramide antigen and alkylated inositol-phosphoglycerolipids expressed by the liver fluke Fasciola hepatica
Glycobiology,
February 1, 2003;
13(2):
129 - 137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. M. Paterson, P. Garside, M. W. Kennedy, and C. E. Lawrence
Modulation of a Heterologous Immune Response by the Products of Ascaris suum
Infect. Immun.,
November 1, 2002;
70(11):
6058 - 6067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Goodridge, E. H. Wilson, W. Harnett, C. C. Campbell, M. M. Harnett, and F. Y. Liew
Modulation of Macrophage Cytokine Production by ES-62, a Secreted Product of the Filarial Nematode Acanthocheilonema viteae
J. Immunol.,
July 15, 2001;
167(2):
940 - 945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Morelle, S. M.Haslam, V. Olivier, J. A. Appleton, H. R. Morris, and A. Dell
Phosphorylcholine-containing N-glycans of Trichinella spiralis: identification of multiantennary lacdiNAc structures
Glycobiology,
September 1, 2000;
10(9):
941 - 950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Tzianabos, R. W. Finberg, Y. Wang, M. Chan, A. B. Onderdonk, H. J. Jennings, and D. L. Kasper
T Cells Activated by Zwitterionic Molecules Prevent Abscesses Induced by Pathogenic Bacteria
J. Biol. Chem.,
March 15, 2000;
275(10):
6733 - 6740.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|